- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01680484
Bitter Chocolate or Orange Juice for Non-reactive Non-stress Test (NST) Patterns
September 6, 2012 updated by: Sertac ESIN, Dr. Sami Ulus Children's Hospital
Bitter Chocolate Versus Orange Juice for Non-reactive Non-stress Test (NST) Patterns: A Randomized Prospective Controlled Study
There are multiple factors affecting the variability and acceleration pattern of fetal heart rate (FHR) pattern.
However, fetal activity is considered as the main determinant.
Any factor decreasing fetal activity causes a decrease in FHR variability.
Fetal activity may be stimulated by manual manipulation, sound, light, change in maternal position and maternal ingestion of glucose.
Among those, ingestion of any kind of food or juice is most frequently practiced in outpatient settings.
This is not only medical but also a social routine.
In this study the investigators have chosen the two most popular so-called 'fetal accelerators', chocolate and orange juice against no intervention and tried to find any usefulness of these on non-reactive NST patterns.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06080
- Dr. Sami Ulus Maternity and Children's Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- singleton pregnancies at 36 to 41 completed gestational weeks that have a non-reactive NST pattern without decelerations.
Exclusion Criteria:
- multiple pregnancies, fetal anomaly, hypertension, intrauterine growth restriction, active labor, contractions or decelerations on NST, absence of a first or second trimester ultrasonography for accurate gestational dating, pre-gestational or gestational diabetes and known allergy to chocolate or orange
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Bitter chocolate
50 grams Ülker Golden %70 bitter chocolate, İstanbul, Turkey
|
|
|
ACTIVE_COMPARATOR: Orange juice
Ülker İçim Orange Juice 250 cc, İstanbul, Turkey
|
|
|
NO_INTERVENTION: Control
Sit and rest
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Increase in reactivity of NST
Time Frame: 30 minutes
|
30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Increase in the maternal fetal movement perception
Time Frame: 30 minutes
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sertac Esin, MD, Dr. Sami Ulus Maternity and Children's Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (ACTUAL)
December 1, 2011
Study Completion (ACTUAL)
January 1, 2012
Study Registration Dates
First Submitted
September 4, 2012
First Submitted That Met QC Criteria
September 6, 2012
First Posted (ESTIMATE)
September 7, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
September 7, 2012
Last Update Submitted That Met QC Criteria
September 6, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HEK 10/117-13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nonreassuring Fetal Status
-
Queen Savang Vadhana Memorial Hospital, ThailandCompletedFetal Status, NonreassuringThailand
-
Hospital KemamanCompleted
-
Ladoke Akintola University of Technology Teaching...Recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingDeterminant of Fetal Growth Retardation After Sleeve Gastrectomy: Involvement of Ghrelin (FG-SLEEVE)Bariatric Surgery Status Complicating Pregnancy | Sleeve Gastrectomy | In Utero Growth RetardationFrance
-
Research Institute of Child Nutrition, DortmundCompletedIron Status | Fatty Acid StatusGermany
-
University of CopenhagenUniversity of Aberdeen; University of Stirling; Noakhali Science and Technology... and other collaboratorsNot yet recruitingNutritional Status | Climate Change | Micronutrient Status | Omega 3 Fat Status | Fish Consumption | Dietary Pattern | Female AutonomyBangladesh
-
Assiut UniversityNot yet recruitingFetal Echocardiography | Fetal Anemia
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...CompletedFemale Genital Mutilation Type I Status | Female Genital Mutilation Type II Status | Female Genital Mutilation Type III StatusItaly
-
North-West University, South AfricaMedical Research Council, South Africa; National Research Foundation of South... and other collaboratorsCompletedMalnutrition | Vitamin A Status | Iron Status | Zinc StatusSouth Africa
-
The First Affiliated Hospital of Xiamen UniversityEnrolling by invitationFetal Clavicle Length | Fetal Scapular Width | Fetal Sternal Length | Fetal Scapular Length | Perinatal Outcomes of the Mother and FetusChina
Clinical Trials on Bitter chocolate
-
Universitas Muhammadiyah SurakartaCompletedType 2 Diabetes Mellitus (T2DM)Indonesia
-
Universitas Muhammadiyah SurakartaNot yet recruitingHyperglycemia | Type 2 Diabetes Mellitus (T2DM)
-
King Saud UniversityRecruitingCardiovascular Health During Prolonged SittingSaudi Arabia
-
Laval UniversityCompleted
-
San Diego State UniversityActive, not recruitingCardiovascular DiseasesUnited States
-
Universidad de AntioquiaTerminated
-
University of Roma La SapienzaCompleted
-
Midwest Center for Metabolic and Cardiovascular...Greenyn BiotechnologyCompleted